Baxion
Screening
Tags
Alerts
Theme
Artelo Biosciences, Inc.
ARTL
·
NASDAQ
·
$1.71
Share Price as of 11/2
·
$4M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q/A
Q2 ended 06/30/26
08/20/26
10-Q
Q2 ended 06/30/26
08/12/26
10-Q
Q1 ended 03/31/26
05/14/26
10-K
FY 2025
02/24/26
10-Q
Q3 ended 09/30/25
11/12/25
Disclosures
Filter
8-K
Current report
10/09/26
8-K
Current report
08/27/26
8-K
Current report
07/17/26
8-K
Current report
05/27/26
8-K
Current report
05/15/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
05/26/26
424B5
Prospectus supplement
05/18/26
S-3/A
Shelf registration (amended)
05/14/26
S-3
Shelf registration
05/04/26
424B3
Prospectus
04/16/26
Proxies
Filter
DEFA14A
Additional proxy materials
07/16/26
DEFA14A
Additional proxy materials
07/16/26
DEFA14A
Additional proxy materials
07/02/26
PRER14A
Preliminary proxy (revised)
06/22/26
DEF 14A
Definitive proxy
06/05/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Form 4
Insider transaction
07/21/26
Form 4
Insider transaction
07/21/26
Form 4
Insider transaction
07/21/26
Other
Filter
ARS
Annual report to shareholders
06/05/26
EFFECT
Request for effectiveness
05/19/26
CORRESP
Correspondence with the SEC
05/15/26
UPLOAD
Letter from the SEC
05/11/26
EFFECT
Request for effectiveness
04/15/26
Latest Filings
Filter
8-K
Current report
10/09/26
8-K
Current report
08/27/26
10-Q/A
Q2 ended 06/30/26
08/20/26
10-Q
Q2 ended 06/30/26
08/12/26
8-K
Current report
07/17/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Form 4
Insider transaction
07/21/26
Form 4
Insider transaction
07/21/26
Form 4
Insider transaction
07/21/26